17β-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Caliceti, Cristiana ^a   Aquila, Giorgio ^a   Pannella, Micaela ^a   Morelli, Marco Bruno ^a   Fortini, Cinzia ^a   Pinton, Paolo ^b   Bonora, Massimo ^b   Hrelia, Silvana ^c   Pannuti, Antonio ^d   Miele, Lucio ^d   Rizzo, Paola ^a   Ferrari, Roberto ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GAMMA SECRETASE INHIBITOR; HYBRID PROTEIN; JAGGED1; LY 374973; MATRIGEL; MESSENGER RNA; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PLACEBO; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN A DELTA LIKE LIGAND 4 NOTCH 1 AXIS;

ANGIOGENESIS; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG TARGETING; ESTROGEN ACTIVITY; EXPERIMENTAL MOUSE; EXPLANT; GENE; GENE CONTROL; GENE FUNCTION; GENE INTERACTION; HEART PROTECTION; HEY2 GENE; HORMONE PROTEIN COMPLEX; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NOTCH1 GENE; NOTCH2 GENE; NOTCH4 GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR RING;

ANIMALS; ENDOTHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MEMBRANE PROTEINS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84881506349     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071440     Document Type: Article

References (62)

1. Kopan R, Ilagan MX (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137: 216-233. S0092-8674(09)00382-1 [pii]; doi:10.1016/j.cell.2009.03.045.
2. Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, et al. (2008) Rational targeting of Notch signaling in cancer. Oncogene 27: 5124-5131. onc2008226 [pii]; doi:10.1038/onc.2008.226.
3. Gu JW, Rizzo P, Pannuti A, Golde T, Osborne B, et al. (2012) Notch signals in the endothelium and cancer stem-like cells: opportunities for cancer therapy. Vasc Cell 4: 7. 2045-824X-4-7 [pii]; doi:10.1186/2045-824X-4-7.
4. Rizzo P, Miele L, Ferrari R (2012) The Notch Pathway: a crossroad between the life and death of the endothelium. Eur Heart J.
5. Sainson RC, Harris AL, (2008) Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies. Angiogenesis 11: 41-51 doi:10.1007/s10456-008-9098-0.
6. Benedito R, Rocha SF, Woeste M, Zamykal M, Radtke F, et al. (2012) Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 484: 110-114. nature10908 [pii]; doi:10.1038/nature10908.
7. Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, et al. (2007) Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res 100: 70-78. 01.RES.0000254788.47304.6e [pii]; doi:10.1161/01.RES.0000254788.47304.6e.
8. Saltiki K, Alevizaki M, (2007) Coronary heart disease in postmenopausal women; the role of endogenous estrogens and their receptors. Hormones (Athens) 6: 9-24.
9. Arnal JF, Fontaine C, Billon-Gales A, Favre J, Laurell H, et al. (2010) Estrogen receptors and endothelium. Arterioscler Thromb Vasc Biol 30: 1506-1512. 30/8/1506 [pii]; doi:10.1161/ATVBAHA.109.191221.
10. Rizzo P, Miao H, D'Souza G, Osipo C, Song LL, et al. (2008) Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 68: 5226-5235. 68/13/5226 [pii]; doi:10.1158/0008-5472.CAN-07-5744.
11. Afshar Y, Miele L, Fazleabas AT (2012) Notch1 is regulated by chorionic gonadotropin and progesterone in endometrial stromal cells and modulates decidualization in primates. Endocrinology 153: 2884-2896. en.2011-2122 [pii]; doi:10.1210/en.2011-2122.
12. Afshar Y, Jeong JW, Roqueiro D, DeMayo F, Lydon J, et al. (2012) Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse. FASEB J 26: 282-294. fj.11-184663 [pii]; doi:10.1096/fj.11-184663.
13. Ruiz-Palmero I, Simon-Areces J, Garcia-Segura LM, Arevalo MA, (2011) Notch/neurogenin 3 signalling is involved in the neuritogenic actions of oestradiol in developing hippocampal neurones. J Neuroendocrinol 23: 355-364 doi:10.1111/j.1365-2826.2011.02110.x.
14. Bender RA, Zhou L, Wilkars W, Fester L, Lanowski JS, et al. (2010) Roles of 17ss-estradiol involve regulation of reelin expression and synaptogenesis in the dentate gyrus. Cereb Cortex 20: 2985-2995. bhq047 [pii]; doi:10.1093/cercor/bhq047.
15. Soares R, Balogh G, Guo S, Gartner F, Russo J, et al. (2004) Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol 18: 2333-2343. me.2003-0362 [pii]. doi:10.1210/me.2003-0362.
16. Sobrino A, Mata M, Laguna-Fernandez A, Novella S, Oviedo PJ, et al. (2009) Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells. PLoS One 4: e8242 doi:10.1371/journal.pone.0008242.
17. Yamaoka-Tojo M, Ushio-Fukai M, Hilenski L, Dikalov SI, Chen YE, et al. (2004) IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation. Circ Res 95: 276-283. 01.RES.0000136522.58649.60 [pii]. doi:10.1161/01.RES.0000136522.58649.60.
18. Cole SP, (1986) Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 17: 259-263.
19. Paschoalin T, Carmona AK, Rodrigues EG, Oliveira V, Monteiro HP, et al. (2007) Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth. Mol Cancer 6: 44. 1476-4598-6-44 [pii]; doi:10.1186/1476-4598-6-44.
20. Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, et al. (2012) Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc 7: 89-104. nprot.2011.435 [pii]; doi:10.1038/nprot.2011.435.
21. Huang J, Kontos CD (2002) PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 277: 10760-10766. M110219200 [pii]. doi:10.1074/jbc.M110219200.
22. Evans MJ, Harris HA, Miller CP, Karathanasis SK, Adelman SJ, (2002) Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways. Endocrinology 143: 3785-3795.
23. Stefano GB, Prevot V, Beauvillain JC, Cadet P, Fimiani C, et al. (2000) Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 101: 1594-1597.
24. Toth B, Scholz C, Saadat G, Geller A, Schulze S, et al. (2009) Estrogen receptor modulators and estrogen receptor beta immunolabelling in human umbilical vein endothelial cells. Acta Histochem 111: 508-519. S0065-1281(08)00063-9 [pii]; doi:10.1016/j.acthis.2008.05.006.
25. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR (2000) Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci U S A 97: 5930-5935. 97/11/5930 [pii].
26. Florian M, Magder S (2008) Estrogen decreases TNF-alpha and oxidized LDL induced apoptosis in endothelial cells. Steroids 73: 47-58. S0039-128X(07)00156-0 [pii]; doi:10.1016/j.steroids.2007.08.010.
27. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM, Losordo DW, (1997) Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 95: 1505-1514.
28. Sumanasekera WK, Sumanasekera GU, Mattingly KA, Dougherty SM, Keynton RS, et al. (2007) Estradiol and dihydrotestosterone regulate endothelial cell barrier function after hypergravity-induced alterations in MAPK activity. Am J Physiol Cell Physiol 293: C566-C573. 00418.2006 [pii]; doi:10.1152/ajpcell.00418.2006.
29. Noseda M, Chang L, McLean G, Grim JE, Clurman BE, et al. (2004) Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Mol Cell Biol 24: 8813-8822. 24/20/8813 [pii]. doi:10.1128/MCB.24.20.8813-8822.2004.
30. Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, et al. (2007) Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst 99: 616-627. 99/8/616 [pii]; doi:10.1093/jnci/djk133.
31. Rosati E, Sabatini R, Rampino G, Tabilio A, Di IM, et al. (2009) Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 113: 856-865. blood-2008-02-139725 [pii]; doi:10.1182/blood-2008-02-139725.
32. Williams CK, Li JL, Murga M, Harris AL, Tosato G (2006) Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 107: 931-939. 2005-03-1000 [pii]; doi:10.1182/blood-2005-03-1000.
33. Rand MD, Grimm LM, Artavanis-Tsakonas S, Patriub V, Blacklow SC, et al. (2000) Calcium depletion dissociates and activates heterodimeric notch receptors. Mol Cell Biol 20: 1825-1835.
34. Funahashi Y, Shawber CJ, Sharma A, Kanamaru E, Choi YK, et al. (2011) Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity. Vasc Cell 3: 2. 2045-824X-3-2 [pii]; doi:10.1186/2045-824X-3-2.
35. Estrach S, Cailleteau L, Franco CA, Gerhardt H, Stefani C, et al. (2011) Laminin-binding integrins induce Dll4 expression and Notch signaling in endothelial cells. Circ Res 109: 172-182. CIRCRESAHA.111.240622 [pii]; doi:10.1161/CIRCRESAHA.111.240622.
36. Funahashi Y, Shawber CJ, Vorontchikhina M, Sharma A, Outtz HH, et al. (2010) Notch regulates the angiogenic response via induction of VEGFR-1. J Angiogenes Res 2: 3. 2040-2384-2-3 [pii]; doi:10.1186/2040-2384-2-3.
37. Quillard T, Devalliere J, Coupel S, Charreau B (2010) Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction. Biochem Pharmacol 80: 2032-2041. S0006-2952(10)00521-6 [pii]; doi:10.1016/j.bcp.2010.07.010.
38. Yang LT, Nichols JT, Yao C, Manilay JO, Robey EA, et al. (2005) Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1. Mol Biol Cell 16: 927-942. E04-07-0614 [pii]; doi:10.1091/mbc.E04-07-0614.
39. Benedito R, Roca C, Sorensen I, Adams S, Gossler A, et al. (2009) The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137: 1124-1135. S0092-8674(09)00324-9 [pii]; doi:10.1016/j.cell.2009.03.025.
40. Borggrefe T, Liefke R (2012) Fine-tuning of the intracellular canonical Notch signaling pathway. Cell Cycle 11: 264-276. 18995 [pii]; doi:10.4161/cc.11.2.18995.
41. Espinoza I, Miele L (2013) Notch inhibitors for cancer treatment. Pharmacol Ther. S0163-7258(13)00044-2 [pii]; doi:10.1016/j.pharmthera.2013.02.003.
42. Hao L, Rizzo P, Osipo C, Pannuti A, Wyatt D, et al. (2010) Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Oncogene 29: 201-213. onc2009323 [pii]; doi:10.1038/onc.2009.323.
43. Peekhaus NT, Chang T, Hayes EC, Wilkinson HA, Mitra SW, et al. (2004) Distinct effects of the antiestrogen Faslodex on the stability of estrogen receptors-alpha and-beta in the breast cancer cell line MCF-7. J Mol Endocrinol 32: 987-995.
44. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, et al. (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87: 905-931. 87/3/905 [pii]; doi:10.1152/physrev.00026.2006.
45. Fernandez JW, Rezai-Zadeh K, Obregon D, Tan J (2010) EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP. FEBS Lett 584: 4259-4267. S0014-5793(10)00749-0 [pii]; doi:10.1016/j.febslet.2010.09.022.
46. Le BR, Bardin A, Schweisguth F (2005) The roles of receptor and ligand endocytosis in regulating Notch signaling. Development 132: 1751-1762. 132/8/1751 [pii]; doi:10.1242/dev.01789.
47. Hansson EM, Lanner F, Das D, Mutvei A, Marklund U, et al. (2010) Control of Notch-ligand endocytosis by ligand-receptor interaction. J Cell Sci 123: 2931-2942. 123/17/2931 [pii]; doi:10.1242/jcs.073239.
48. Stirone C, Boroujerdi A, Duckles SP, Krause DN (2005) Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol 67: 105-113. mol.104.004465 [pii]; doi:10.1124/mol.104.004465.
49. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, et al. (2006) Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444: 1083-1087. nature05313 [pii]; doi:10.1038/nature05313.
50. Al Haj ZA, Oikawa A, Bazan-Peregrino M, Meloni M, Emanueli C, et al. (2010) Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. Circ Res 107: 283-293. CIRCRESAHA.110.221663 [pii]; doi:10.1161/CIRCRESAHA.110.221663.
51. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, et al. (1995) Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91: 755-763.
52. Jesmin S, Sakuma I, Hattori Y, Kitabatake A, (2002) In vivo estrogen manipulations on coronary capillary network and angiogenic molecule expression in middle-aged female rats. Arterioscler Thromb Vasc Biol 22: 1591-1597.
53. Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, et al. (2003) Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107: 3059-3065. 01.CIR.0000077911.81151.30 [pii]. doi:10.1161/01.CIR.0000077911.81151.30.
54. Sainson RC, Johnston DA, Chu HC, Holderfield MT, Nakatsu MN, et al. (2008) TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 111: 4997-5007. blood-2007-08-108597 [pii]; doi:10.1182/blood-2007-08-108597.
55. Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, et al. (2012) Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 345: e6409.
56. Dubey RK, Imthurn B, Barton M, Jackson EK (2005) Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res 66: 295-306. S0008-6363(04)00584-X [pii]; doi:10.1016/j.cardiores.2004.12.012.
57. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333. joc21036 [pii].
58. Gray S (2003) Breast cancer and hormone-replacement therapy: the Million Women Study. Lancet 362: 1332. S0140-6736(03)14598-9 [pii]; doi:10.1016/S0140-6736(03)14598-9.
59. Albain KS (2010) Combination of Notch inhibitor MK-0752 and endocrine therapy for early stage ER alpha breast cancer in a pre-surgical window study. Cancer Res 70 (24 Suppl) 113-114.
60. Kolb EA, Gorlick R, Keir ST, Maris JM, Lock R, et al. (2012) Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a gamma-secretase inhibitor targeting notch signaling. Pediatr Blood Cancer 58: 815-818 doi:10.1002/pbc.23290.
61. Krop I, Demuth T, Guthrie T, Wen PY, Mason WP, et al. (2012) Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol 30: 2307-2313. JCO.2011.39.1540 [pii]; doi:10.1200/JCO.2011.39.1540.
62. Tolcher AW, Messersmith WA, Mikulski SM, Papadopoulos KP, Kwak EL, et al. (2012) Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors. J Clin Oncol 30: 2348-2353. JCO.2011.36.8282 [pii]; doi:10.1200/JCO.2011.36.8282.